|
|
Other links at Articles > Business of Medicine |
| 4. |
U.S. FDA Official Sees Some Delays Over Safety
|
|
|
A new focus on drug safety is delaying the approval of some medicines as regulators impose requirements meant to minimize side effects, a top U.S. drug regulator told Reuters on Tuesday. Reuters Health Information
|
|
|